Jobless Claims Decline to Lowest Level Since MidMay Signaling Labor Market Resilience Trump Expresses Dissatisfaction with Iran Nuclear Deal Talks Heightening Geopolitical Uncertainty Zama Acquires TokenOps to Enable Confidential and Compliant Token Distributions Airdrops and Vesting RBI Approves Sandeep Bakhshis Reappointment as ICICI Bank CEO for Two More Years Waymo Temporarily Halts Robotaxi Operations in Five US Cities Following FloodRelated Incidents Viatris Inc Attracts Analyst Attention Amid Strategic Portfolio Shifts TROW Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Market Performance Vertex Inc VERX Q1 2026 Earnings EPS Beat Drives Modest Share Gains Revenue Unreported SPME Q1 2026 Earnings EPS Misses Estimates by Nearly 20 as Preferred Shares Edge Lower COSM Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines Slightly NVDA Q1 2026 Earnings Strong EPS Beat Amid Market Caution XPEL Q1 2026 Earnings Narrow Earnings Beat as Profitability Holds Steady A SPAC III Acquisition Corp ASPC Moves Lower as Support Near 1027 Remains in Focus Campbells Company CPB Rallies 264 as Shares Approach Key Resistance Level Firefly Aerospace Inc FLY Soars 155 Key Levels to Watch Biote Corp BTMD Extends Decline Down 386 as Support Level Comes into Focus C4 Therapeutics CCCC Surges 7 Biotech Momentum Test Key Resistance Wix CEO Avishai Abrahami Announces 20 Workforce Reduction Citing AI Integration SOLS Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Sleep Number Corporation SNBR Bounces from Support Potential Reversal or Temporary Relief Huachen AI Parking HCAI Drops 10 Testing Key Support as Selling Pressure Intensifies Provident Financial Holdings PROV Posts Modest Gain as Stock Holds Above Support 707 Cayman Holdings Limited JEM Sees Modest Gain Amid Narrow Trading Range Harvard Ave Acquisition Corp Unit HAVAU Holds Steady Near Trust Value With No Price Movement MBINL Preferred Shares Edge Higher as Income Investors Seek Stability Health In Tech Inc HIT Surges 788 Approaching Key Resistance at 098 Myriad Genetics Slips 23 to 382 as Shares Test Key Support Levels